Stock screenerAll disclosures →
EDGAR →
VERA
Conviction 47HealthcareScan · Thu, Jun 25, 2026VERA$40.48+2.46%
ResistanceSupportVol 14Insider sell2
3
Vol MA14 1.77M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price40.48
Change+2.46%
Gap+0.66%
Rel volume6.20×
Avg volume1.71M
Avg $ vol61.77M
SMA 2034.56
SMA 5036.11
SMA 20037.49
Price vs 50+12.10%
Price vs 200+7.98%
MA stackmixed
50/200 crossdeath · 7d
Supertrendup · 34.19
RSI (14)69
MACD hist0.98
MACD crossbull · 9d
Stoch %K / %D89 / 92
ADX (14)22
+DI / −DI36 / 12
RSI divergence—
MACD divergence—
ATR %+5.25%
ADR %6.51%
52w high55.67
52w low19.25
From 52w high-27.29%
Above 52w low+110.29%
New 52w highNo
SqueezeOff
Bollinger width31.21%
%B1.05
Donchian pos89.50%
Donchian high41.64
Donchian low30.59
AVWAP (52w high)40.59
vs AVWAP high-0.27%
AVWAP (52w low)35.13
vs AVWAP low+15.23%
OBV trendUp
Chaikin MF (20)-0.03
Today vs 20d6.20×
Avg vol (14d)1.77M
Avg vol (20d)1.71M
Avg $ vol (20d)61.77M
Market cap2.91B
RS 3m (vs SPY)-12.86%
RS 6m (vs SPY)-30.60%
RS line new highNo
Trend template4/8
Technical rank61.4
1 week+15.62%
1 month+17.88%
3 months+0.80%
6 months-24.73%
1 year+79.27%
YTD-16.74%
P/E-9.70
P/B5.82
P/S—
P/FCF-12.02
EPS-4.66
Div yield—
ROE-59.96%
ROA-48.19%
Debt/Eq0.15
Current13.64
EV/EBITDA-9.10
Gross margin—
Net margin—
Rev growth—
EPS growth-96.92%
Price target80.09
Target upside97.85%
Analyst ratingBuy
Institutional105.80%
Ent. value2.87B
Revenue—
Net income-121.03M
Gross profit—
Free cash flow-241.73M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out71.78M
Employees339
ListedFri, May 14, 2021
Free float62.91M
Float %87.7%
Short interest10.83M
Days to cover11.2d
Short volume62.4%
Squeeze score89 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$1.60 · 5 est
Last EPS vs est−$1.69 vs −$1.26
Last surprise-34.1% miss
Setup gradeC
Conviction47 / 100
Pattern quality—
Tech rank61.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance38.59
Support30.71
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in VERA
No recent disclosed trades by Congress in VERA. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in VERA · 8 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Cheng Andrew Director · Stock Option (right to buy) · 2026-05-21 | Grant | 17.08K | $0 | 2026-05-21 | 2026-05-26 |
Hall Kimball Director · Stock Option (right to buy) · 2026-05-21 | Grant | 17.08K | $0 | 2026-05-21 | 2026-05-26 |
MORRISSEY MICHAEL Director · Stock Option (right to buy) · 2026-05-21 | Grant | 17.08K | $0 | 2026-05-21 | 2026-05-26 |
Oliger Christy J. Director · Stock Option (right to buy) · 2026-05-21 | Grant | 17.08K | $0 | 2026-05-21 | 2026-05-26 |
Meyers James R Director · Stock Option (right to buy) · 2026-05-21 | Grant | 17.08K | $0 | 2026-05-21 | 2026-05-26 |
SEIDENBERG BETH C Director · Stock Option (right to buy) · 2026-05-21 | Grant | 17.08K | $0 | 2026-05-21 | 2026-05-26 |
ENRIGHT PATRICK G Director · Stock Option (right to buy) · 2026-05-21 | Grant | 17.08K | $0 | 2026-05-21 | 2026-05-26 |
Morrison Scott W Director · Stock Option (right to buy) · 2026-05-21 | Grant | 17.08K | $0 | 2026-05-21 | 2026-05-26 |
Fordyce Marshall PRESIDENT AND CEO · Class A Common Stock · 2026-05-12 | Other | — | — | 2026-05-12 | 2026-05-13 |
Fordyce Marshall PRESIDENT AND CEO · Class A Common Stock · 2026-05-12 | Sell | 14.22K | $521K | 2026-05-12 | 2026-05-13 |
SEC filings
EDGAR filings in VERA · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.